Pfizer
Pfizer raises 2021 outlook on surging COVID-19 vaccine sales
Pfizer Chief Executive Officer Albert Bourla said more than a billion doses of the vaccine have been delivered, saying "the speed and efficiency of our efforts...
-
Vaccine update: 2.1 million Pfizer shots expected to be delivered in July
Acting Minister of Health Mmamoloko Kubayi-Ngubane has given an update on the COVID-19 vaccine rollout plan on 2 July 2021. She said the country was expecting more vaccines in the coming weeks and that the number of vaccinations had surpassed 120,000 per day, with almost 300,000 education staff vaccinated so far.
-
US buying 500 mn doses of Pfizer COVID vaccine for world: US media
The move comes as the United States faces pressure to do more about the global vaccine shortage, with rich countries having bought up the lion's share of early supplies.
-
Gauteng govt now prepares to vaccinate 1.3 million people against COVID
Phase two of the COVID-19 vaccine roll-out began on Monday, with priority given to South Africans who are over 60-years-old, while thousands of health workers who are yet to receive their jabs will also be accommodated.
-
Mkhize: Generators ready to ensure power cuts don't affect vaccine storage
The stage two blackouts are expected to last until Tuesday night but as always, there’s no guarantee.
-
SA takes delivery of first batch of Pfizer vaccines
The first batch of Pfizer vaccines arrived in South Africa in the late evening of 2 May 2021. #Pfizer #vaccines #covid19news
-
SA officially expands mass inoculation drive with arrival of Pfizer vaccines
More than 325,000 doses arrived at OR Tambo International Airport just before Sunday midnight.
-
Pfizer CEO: Vaccine third dose 'likely' needed within 12 months
Pfizer published a study earlier this month that said its jab is more than 91% effective at protecting against the coronavirus, and more than 95% effective against severe cases of COVID-19 up to six months after the second dose.
-
EU to get 50 million Pfizer doses early as US prolongs J&J pause
Concerns over using the J&J and AstraZeneca vaccines have dampen hopes that mass immunizations will lead to a swift exit from the global pandemic that has killed nearly three million people and ravaged the global economy.
-
Pfizer vaccine ready for distribution as SAHPRA approves emergency use
South Africa has already ordered 20 million doses of the Pfizer vaccine, which is now available for use via an instrument used for emergency access use of non-registered health products.
-
Rivals turn partners for COVID-19 vaccine challenge
The latest tie-up involves US giant Merck which agreed to help produce the potentially key one-shot vaccine developed by Johnson & Johnson.
-
Mkhize among many politicians willing to take COVID vaccine first
But this has been met with criticism as some believe ministers are using this opportunity to jump the queue to get their hands on the lifesaving jabs.
-
Pfizer estimates $15 bn in 2021 sales for COVID-19 vaccine
The projections came as Pfizer projected full-year 2021 sales of between $59.4 billion and $61.4 billion, meaning that about one-fourth of estimated total sales will come from the COVID-19 vaccine.
-
More than 100 million vaccinated across the globe
None of the world's 29 poorest countries has formally started mass vaccination drives, while the richest nations have given more than two-thirds of jabs administered.
-
Blow to global vaccine drive as Pfizer delays deliveries
Pfizer said the modifications at the Puurs factory were necessary in order to ramp up its production capacity from mid-February of the vaccine developed with Germany's BioNTech.
-
Pfizer delays vaccine deliveries to 8 EU nations: Spain
The Spanish branch of Pfizer informed Madrid on Sunday night of the delay in shipments to the eight nations due to a 'problem in the loading and shipment process' at its plant in Belgium, the health ministry said in a statement.
-
US drug regulator denies inteference over Pfizer vaccine
The FDA issued an emergency use authorization for the two-dose regimen late on Friday night following reports President Donald Trump had threatened to fire the head of the agency if he didn't act that day.
-
US considers Pfizer COVID-19 vaccine approval
Pfizer scientist Kathrin Jansen told the panel this was a result of the innovative messenger RNA technology behind the vaccine, an approach that has never before been approved.
-
Israel gets first delivery of Pfizer COVID-19 vaccine
The shipment was the first of eight million doses ordered from US pharmaceutical giant Pfizer BioNTech.
